Medibank Private Limited (ASX:MPL)
Australia flag Australia · Delayed Price · Currency is AUD
4.810
-0.030 (-0.62%)
Sep 1, 2026, 4:10 PM AEST

Medibank Private Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Premiums & Annuity Revenue
8,6528,0127,6237,0866,881
Total Interest & Dividend Income
197.4176.1164.3108.255.9
Gain (Loss) on Sale of Investments
-1533.819.530.4-80.7
Other Revenue
463334.7222.8173.3248.3
9,2988,5568,0307,3987,105
Revenue Growth
8.66%6.56%8.53%4.13%1.03%
Policy Benefits
7,0346,6556,2896,0575,680
Depreciation & Amortization
----115
Selling, General & Administrative
690.3656.6619.5566.6290.4
Other Operating Expenses
616.6494.2396.7333.5-
Total Operating Expenses
8,3417,8067,3066,9576,547
Operating Income
956.4750.8724.2441.1557.9
Interest Expense
-15.8-11-5.4-1.8-2.4
Earnings From Equity Investments
-12.7-11-7.1-1.44.5
EBT Excluding Unusual Items
927.9728.8711.7437.9560
Pretax Income
927.9728.8711.7437.9560
Income Tax Expense
281.6219.5215.3129.3166.1
Earnings From Continuing Ops.
646.3509.3496.4308.6393.9
Net Income to Company
646.3509.3496.4308.6393.9
Minority Interest in Earnings
-7.6-8.5-3.9--
Net Income
638.7500.8492.5308.6393.9
Net Income to Common
638.7500.8492.5308.6393.9
Net Income Growth
27.54%1.69%59.59%-21.65%-10.72%
Shares Outstanding (Basic)
2,7542,7542,7542,7542,754
Shares Outstanding (Diluted)
2,7542,7542,7542,7542,754
Shares Change
-----
EPS (Basic)
0.230.180.180.110.14
EPS (Diluted)
0.230.180.180.110.14
EPS Growth
27.54%1.69%59.59%-21.65%-10.72%

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
492.2369.7861.5176.7941.5
Free Cash Flow Per Share
0.180.130.310.060.34
Dividend Per Share
0.1920.1800.1660.1460.134
Dividend Growth
6.67%8.43%13.70%8.96%5.51%
Operating Margin
10.29%8.77%9.02%5.96%7.85%
Profit Margin
6.87%5.85%6.13%4.17%5.54%
Free Cash Flow Margin
5.29%4.32%10.73%2.39%13.25%
EBITDA
975.5768.6738.1454.2571.2
EBITDA Margin
10.49%8.98%9.19%6.14%8.04%
D&A For EBITDA
19.117.813.913.113.3
EBIT
956.4750.8724.2441.1557.9
EBIT Margin
10.29%8.77%9.02%5.96%7.85%
Effective Tax Rate
30.35%30.12%30.25%29.53%29.66%